Guy Brachya

663 total citations
7 papers, 383 citations indexed

About

Guy Brachya is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Guy Brachya has authored 7 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Guy Brachya's work include Immune Cell Function and Interaction (3 papers), CAR-T cell therapy research (2 papers) and Immunotherapy and Immune Responses (2 papers). Guy Brachya is often cited by papers focused on Immune Cell Function and Interaction (3 papers), CAR-T cell therapy research (2 papers) and Immunotherapy and Immune Responses (2 papers). Guy Brachya collaborates with scholars based in Israel, United States and Finland. Guy Brachya's co-authors include Zoltán Wiener, Irit Snir-Alkalay, Robert E. Goldstein, Yael Morgenstern, Ela Elyada, Ariel Pribluda, Moshe Oren, Kari Alitalo, Eli Pikarsky and Yinon Ben‐Neriah and has published in prestigious journals such as Nature, Blood and Cancer Cell.

In The Last Decade

Guy Brachya

7 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guy Brachya Israel	6	223	134	108	76	62	7	383
Μαρία Ζαμανάκου Greece	10	139 0.6×	143 1.1×	241 2.2×	37 0.5×	56 0.9×	20	517
Youndong Kim South Korea	11	267 1.2×	98 0.7×	113 1.0×	31 0.4×	49 0.8×	14	398
Michael S. Lam United States	9	152 0.7×	44 0.3×	75 0.7×	70 0.9×	103 1.7×	13	365
Colin Carlock United States	10	232 1.0×	129 1.0×	128 1.2×	29 0.4×	56 0.9×	16	463
Andrew S. Gilder United States	13	276 1.2×	79 0.6×	121 1.1×	43 0.6×	147 2.4×	16	517
Hirotada Akiyama Japan	16	481 2.2×	161 1.2×	98 0.9×	38 0.5×	63 1.0×	26	579
Katarzyna M. Wilczynska United States	11	347 1.6×	60 0.4×	104 1.0×	34 0.4×	115 1.9×	11	476
Olivia Lanvin France	12	246 1.1×	101 0.8×	73 0.7×	33 0.4×	68 1.1×	14	420
Raffaella Spina United States	10	230 1.0×	64 0.5×	39 0.4×	32 0.4×	88 1.4×	15	325
Maja Sirotković-Skerlev Croatia	10	145 0.7×	81 0.6×	47 0.4×	32 0.4×	53 0.9×	20	319

Countries citing papers authored by Guy Brachya

Since Specialization

Citations

This map shows the geographic impact of Guy Brachya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Brachya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Brachya more than expected).

Fields of papers citing papers by Guy Brachya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy Brachya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Brachya. The network helps show where Guy Brachya may publish in the future.

Co-authorship network of co-authors of Guy Brachya

This figure shows the co-authorship network connecting the top 25 collaborators of Guy Brachya. A scholar is included among the top collaborators of Guy Brachya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy Brachya. Guy Brachya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Bachanová, Veronika, David H. McKenna, Xianghua Luo, et al.. (2019). Results of a Phase 1 Trial of Gda-201, Nicotinamide-Expanded Allogeneic Natural Killer Cells (NAM-NK) in Patients with Refractory Non-Hodgkin Lymphoma (NHL) and Multiple Myeloma (MM). Blood. 134(Supplement_1). 777–777. 5 indexed citations

2.

Bachanová, Veronika, David H. McKenna, Xianghua Luo, et al.. (2019). First-in-Human Phase I Study of Nicotinamide-Expanded Related Donor Natural Killer Cells for the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma and Multiple Myeloma. Biology of Blood and Marrow Transplantation. 25(3). S175–S176. 12 indexed citations

3.

Peled, Tony, Guy Brachya, Efrat Landau, et al.. (2017). Enhanced In Vivo Persistence and Proliferation of NK Cells Expanded in Culture with the Small Molecule Nicotinamide: Development of a Clinical-Applicable Method for NK Expansion. Blood. 130(Suppl_1). 657–657. 7 indexed citations

4.

Pribluda, Ariel, Ela Elyada, Zoltán Wiener, et al.. (2015). A Senescence-Inflammatory Switch from Cancer-Inhibitory to Cancer-Promoting Mechanism. Cancer Cell. 27(6). 877–878. 3 indexed citations

5.

Pribluda, Ariel, Ela Elyada, Zoltán Wiener, et al.. (2013). A Senescence-Inflammatory Switch from Cancer-Inhibitory to Cancer-Promoting Mechanism. Cancer Cell. 24(2). 242–256. 185 indexed citations

6.

Elyada, Ela, Ariel Pribluda, Robert E. Goldstein, et al.. (2011). CKIα ablation highlights a critical role for p53 in invasiveness control. Nature. 470(7334). 409–413. 150 indexed citations

7.

Brachya, Guy, et al.. (2006). Synaptic proteins as multi-sensor devices of neurotransmission. BMC Neuroscience. 7(S1). S4–S4. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact